Literature DB >> 11096008

Review of false-positive cultures for Mycobacterium tuberculosis and recommendations for avoiding unnecessary treatment.

W J Burman1, R R Reves.   

Abstract

We reviewed reports of false-positive cultures for Mycobacterium tuberculosis and here propose guidelines for detecting and managing patients with possible false-positive cultures. Mechanisms of false-positive cultures included contamination of clinical devices, clerical errors, and laboratory cross-contamination. False-positive cultures were identified in 13 (93%) of the 14 studies that evaluated > or = 100 patients; the median false-positive rate was 3.1% (interquartile range, 2.2%-10.5%). Of the 236 patients with false-positive cultures reported in sufficient detail, 158 (67%) were treated, some of whom had toxicity from therapy, as well as unnecessary hospitalizations, tests, and contact investigations. Having a single positive culture was a sensitive but nonspecific criterion for detecting false-positive cultures. False-positive cultures for M. tuberculosis are not rare but are infrequently recognized by laboratory and clinical personnel. Laboratories and tuberculosis control programs should develop procedures to identify patients having only 1 positive culture. Such patients should be further evaluated for the possibility of a false-positive culture.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11096008     DOI: 10.1086/317504

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  31 in total

1.  Molecular epidemiology of Mycobacterium tuberculosis in Norway.

Authors:  U R Dahle; P Sandven; E Heldal; D A Caugant
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

2.  Estimation of the rate of unrecognized cross-contamination with mycobacterium tuberculosis in London microbiology laboratories.

Authors:  M Ruddy; T D McHugh; J W Dale; D Banerjee; H Maguire; P Wilson; F Drobniewski; P Butcher; S H Gillespie
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

Review 3.  The Ontario universal typing of tuberculosis (OUT-TB) surveillance program--what it means to you.

Authors:  Shelly Bolotin; David C Alexander; Jennifer L Guthrie; Steven J Drews; Frances Jamieson
Journal:  Can Respir J       Date:  2010 May-Jun       Impact factor: 2.409

4.  False-positive tuberculous meningitis due to laboratory contamination: importance of a holistic clinical evaluation.

Authors:  Saraschandra Vallabhajosyula; Renuga Vivekanandan; Edward A Horowitz
Journal:  BMJ Case Rep       Date:  2014-05-21

5.  Tuberculosis mortality, drug resistance, and infectiousness in patients with and without HIV infection in Peru.

Authors:  Vivian Kawai; Giselle Soto; Robert H Gilman; Christian T Bautista; Luz Caviedes; Luz Huaroto; Eduardo Ticona; Jaime Ortiz; Marco Tovar; Victor Chavez; Richard Rodriguez; A Roderick Escombe; Carlton A Evans
Journal:  Am J Trop Med Hyg       Date:  2006-12       Impact factor: 2.345

6.  Laboratory Cross-Contamination of Mycobacterium tuberculosis: A Systematic Review and Meta-analysis.

Authors:  Aleksandra Barac; Hannah Karimzadeh-Esfahani; Mahya Pourostadi; Mohammad Taghi Rahimi; Ehsan Ahmadpour; Jalil Rashedi; Behroz Mahdavipoor; Hossein Samadi Kafil; Adel Spotin; Kalkidan Hassen Abate; Alexander G Mathioudakis; Mohammad Asgharzadeh
Journal:  Lung       Date:  2019-06-15       Impact factor: 2.584

7.  Trends in Testing for Mycobacterium tuberculosis Complex From US Public Health Laboratories, 2009-2013.

Authors:  Frances Tyrrell; Cortney Stafford; Mitchell Yakrus; Monica Youngblood; Andrew Hill; Stephanie Johnston
Journal:  Public Health Rep       Date:  2016-12-12       Impact factor: 2.792

8.  A prospective, multicenter study of laboratory cross-contamination of Mycobacterium tuberculosis cultures.

Authors:  Robert M Jasmer; Marguerite Roemer; John Hamilton; John Bunter; Christopher R Braden; Thomas M Shinnick; Edward P Desmond
Journal:  Emerg Infect Dis       Date:  2002-11       Impact factor: 6.883

9.  Estimated costs of false laboratory diagnoses of tuberculosis in three patients.

Authors:  Jill M Northrup; Ann C Miller; Edward Nardell; Sharon Sharnprapai; Sue Etkind; Jeffrey Driscoll; Michael McGarry; Harry W Taber; Paul Elvin; Noreen L Qualls; Christopher R Braden
Journal:  Emerg Infect Dis       Date:  2002-11       Impact factor: 6.883

10.  Molecular epidemiology of tuberculosis in a low- to moderate-incidence state: are contact investigations enough?

Authors:  Wendy A Cronin; Jonathan E Golub; Monica J Lathan; Leonard N Mukasa; Nancy Hooper; Jafar H Razeq; Nancy G Baruch; Donna Mulcahy; William H Benjamin; Laurence S Magder; G Thomas Strickland; William R Bishai
Journal:  Emerg Infect Dis       Date:  2002-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.